No Detail Found!

Antiproliferative activity of 3,5-disubstituted tetrahydro-2H-1,3,5- thiadiazine thione (THTT) derivatives and evaluation as potential prodrug

Author(s)
Nuzhat Arshad Department of Chemistry, NED University of Engineering and Technology, Karachi, Pakistan; H.E.J. Research Institute of Chemistry, ICCBS, University of Karachi, Karachi, Pakistan
Muhammad Yaseen Institute of Chemical Sciences, University of Peshawar, Peshawar, Pakistan
Jamshed Hashim H.E.J. Research Institute of Chemistry, ICCBS, University of Karachi,Karachi,Pakistan
Irfan Ullah H.E.J. Research Institute of Chemistry, ICCBS, University of Karachi, Karachi, Pakistan; Institute of Chemical Sciences, University of Peshawar, Peshawar, Pakistan
Rasool Khan Institute of Chemical Sciences, University of Peshawar, Peshawar, Pakistan
Iqbal Safi H.E.J. Research Institute of Chemistry, ICCBS, University of Karachi, Karachi, Pakistan; Institute of Chemical Sciences, University of Peshawar, Peshawar, Pakistan
Aqeela Rafique H.E.J. Research Institute of Chemistry, ICCBS, University of Karachi, Karachi, Pakistan
Qurat-ul-Ain Hanif Department of Chemistry, NED University of Engineering and Technology, Karachi, Pakistan; H.E.J. Research Institute of Chemistry, ICCBS, University of Karachi, Karachi, Pakistan
Umme Attia Kulsoom H.E.J. Research Institute of Chemistry, ICCBS, University of Karachi, Karachi, Pakistan; Institute of Chemical Sciences, University of Peshawar,Peshawar,Pakistan
Abstract
Four series of tetrahydro-2H-1,3,5-thiadiazine thione derivatives were screened for their in vitro antiproliferative activities against two human cancerous PC3 and HeLa cell lines. The cytotoxicity of all the compounds (series A-D) was also determined on mammalian mouse fibroblast 3T3 cells. Most of the compounds showed significant anticancer potential against both cancer cell lines within the range of IC50 = 6.4-29.9 and 2.4-23.8 mM respectively when compared with standard doxorubicin (IC50 = 0.3 mM). All compounds demonstrated a notable selectivity for Hela cells and found either non-toxic or relatively less toxic for 3T3 cell lines model. The structure-activity relationship indicated that antiproliferative activity mainly influenced by the nature and position of substituents at thidiazine nucleus. In general, the presence of aryl groups for example 3,4-(OMe)2.Bzl and CH(Ph)Me at N-3 position resulted in a significant activity. Under enzymatic hydrolysis, complete conversion (100%) of ester derivative of thiadiazine thione (10a) into its acidic counterpart (7c) was achieved during 20 min which indicated that these types of THTT ester derivatives can be a possible lead for future investigations as prodrug anticancer probes.
Publication Details
Page(s) 773-779
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP2, Year: 2021

Request the full text from PASTIC

Keywords
Anticancer, antiproliferative, Anticancer, 3, 5-thiadiazine thiones, Prodrugs, ester, Tetrahydro-1, Anticancer
References
Aboul-Fadl T,Hussein MA,El-Shorbagi AN,Khallil AR,- AR .2002 .- thiones incorporating glycine and glycinamide as potential antifungal agents. Arch. Pharm. (Weinheim), 335(9) : 438-442.
Akin S,Guner CK .2019 .Investigation of the relationship among fatigue, self-efficacy and quality of life during chemotherapy in patients with breast, lung or gastrointestinal cancer. Eur. J. Cancer Care, 28(1) : e12898.
Arshad N,Hashim J,Ullah I,Minhas MA,Aslam J,Ashraf T,Hamid SZ,Iqbal T,Javed S T .2018 .- thiadiazine thione (THTT) derivatives: Synthesis and potent antileishmanial activity. Bioorg. Med, 28(19) : 3251-3254.
Bermello JC,Piñeiro RP,Fidalgo LM,Cabrera HR,Navarro MS .2011 .Thiadiazine derivatives as antiprotozoal new drugs. Open Med, 5 : 51-60.
Dimas K,Demetzos C,Marsellos M,Sotiriadou R,Malamas M,Kokkinopoulos D M .1998 .Cytotoxic activity of labdane type diterpenes against human leukemic cell lines in vitro. Planta Med, 64(3) : 208-211.
Hamada Y .2017 .Recent progress in prodrug design strategies based on generally applicable modifications. Bioorg. Med, 27(8) : 1627-1632.
Koukourakis GV,Kouloulias V,Koukourakis MJ,Zacharias GA,Zabatis H,Kouvaris J .2008 .Efficacy of the oral fluorouracil pro-drug capecitabine in cancer treatment: A review. Molecules, 13(8) : 1897-1922.
Kumar PV,Rao VR,- VR,Sect VR .2008 .-yl)chromen-2-one and its derivatives. 47B(1), 1(3) : 106-111.
Monzote L,Montalvo AM,Fonseca L,Perez R,Suarez M,Rodríguez H M .2005 .In vitro activities of thiadiazine derivatives against leishmania amazonensis. Arzneim-Forsch/Drug Res., 55(4) : 232-238.
Mosmann T .1983 .Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65(1-2) : 55-63.
Perez R,Rodriguez Ή,Perez E,Suarez M,Reyes O,Gonzalez LJ,Lopez de Cerain A,Ezpelata O,Perez C,Ochoa C C .2000 .Study on the decomposition products of thiadiazinthione and their anticancer properties. Arzneim-forsch/Drug Res., 50(9) : 854-857.
Radwan AA,Al-Dhfyan A,Abdel-Hamid MK,Al-Badr A A,Aboul-Fadl T .2012 .-thiones: New cell-cycle inhibitors. Arch. Pharm. Res., 35(1) : 35-49.
Rashin BK,Sherin A,Shijikumar PS,Sirajudheen MK .2020 .A review on trigonelline containing prodrugs. Int. J. Pharm. Pharm. Res., 19(3) : 386-393.
Satoh T,Hosokawa M .2006 .Structure, function and regulation of carboxylesterases. Chem. Biol. Interact, 162(3) : 195-211.
Semreen MH,El-Shorbagi AN,Al-Tel TH,Alsalahat IMM .2010 .Targeting ϒ-Aminobutyric Acid (GABA) Carriers to the Brain: Potential Relevance as Antiepileptic Pro-Drugs. Med. Chem, 6(3) : 144-149.
Shah K,Gupta JK,Chauhan NS,Upmanyu N,Shrivastava SK,Mishra P .2017 .Prodrugs of NSAIDs: A review. Open Med, 11 : 146-195.
Shi D,Yang J,Yang D,LeCluyse EL,Black C,You L,Akhlaghi F,Yan B .2006 .Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1 and the activation is inhibited by antiplatelet agent clopidogrel. J. Pharmacol. Exp. Ther., 319(3) : 1477-1484.
Sim KM,Teo KC .2018 .]thiadiazines as potential antibacterial agents. Lett. Drug Des, 15(7) : 733-743.
Sung H,Ferlay J,Siegel RL,Laversanne M,Soerjomataram I,Jemal A,Bray F A .2020 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Clin., 0(0) : 1-41.
Wang X,Fu X,Chen M,Wang A,Yan J,Mei Y,Wang M,Yang C,- C .2019 .- thione derivatives containing a hydrazide moiety: Design, synthesis and bioactive evaluation against phytopathogenic fungi in vitro and in vivo. Chin. Chem, 30(7) : 1419-1422.
Yamamoto K,Mano T,Yoshida J,Sakata Y,Nishikawa N,Nishio M,Ohtani T,Hori M,Miwa T,Masuyama T .2005 .ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. J. Hypertens., 23(2) : 393-400.
Zawilska JB,Wojcieszak J,Olejniczak AB .2013 .Prodrugs: A challenge for the drug development. Pharmacol. Rep, 65(1) : 1-14.
Zhao J,Diaz-Dussan D,Jiang Z,Peng YY,White J,Duan W,Narain R,Hao X,Kong L X .2020 .Facile preparation of macromolecular prodrugs for hypoxiaspecific chemotherapy. ACS Macro Lett., 9(11) : 1687-1692.
0

Citations

0

Downloads

10

Views